Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed or Refractory Neuroblastoma
Conditions: Neuroblastoma; Refractory Neuroblastoma; Relapsed Neuroblastoma Intervention: Combination Product: Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate Sponsor: Emory University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials